Patents by Inventor Rossano Cesari

Rossano Cesari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination for Treating Cancer
    Publication number: 20210386826
    Abstract: Provided herein are methods and combinations for treating a subject having cancer by administering to the subject a PD-1/PD-L1 axis inhibitor, a CD-122-biased cytokine agonist, and an anti-androgen or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 4, 2019
    Publication date: December 16, 2021
    Applicants: Pfizer Inc., MERCK PATENT GMBH, NEKTAR THERAPEUTICS, Astellas Pharma Inc.
    Inventors: Christoffel Hendrik Boshoff, Rossano Cesari, Cristian Massacesi, Deborah Charych
  • Combinations for Treating Cancer
    Publication number: 20210355223
    Abstract: Provided herein are methods and combinations for treating a subject having cancer by administering to the subject a PD-1/PD-L1 axis inhibitor, a CD-122-biased-cytokine agonist, and optionally a PARP inhibitor.
    Type: Application
    Filed: November 4, 2019
    Publication date: November 18, 2021
    Inventors: Christoffel Hendrik Boshoff, Rossano Cesari, Cristian Massacesi, Deborah Charych
  • Methods and Combination Therapy to Treat Cancer
    Publication number: 20210077463
    Abstract: This invention relates to a method of treating cancer by administering a combination therapy comprising a combination of a MEK inhibitor and a PD-1 axis binding antagonist, or a combination of a MEK inhibitor and a PARP inhibitor, or a combination of a MEK inhibitor and a PD-1 axis binding antagonist and a PARP inhibitor to a patient in need thereof.
    Type: Application
    Filed: December 17, 2018
    Publication date: March 18, 2021
    Inventors: Christoffel Hendrik Boshoff, Rossano Cesari, Cristian Massacesi, Nuzhat Pathan, Patrice A. Lee, Shannon L. Winski
  • Combination of a PARP Inhibitor and a PD-1 Axis Binding Antagonist
    Publication number: 20200254091
    Abstract: This invention relates to a method of treating cancer by administering a PARP inhibitor in combination with a PD-1 axis binding antagonist to a patient in need thereof.
    Type: Application
    Filed: October 10, 2018
    Publication date: August 13, 2020
    Inventors: John Andrew Blake-Haskins, Christoffel Hendrik Boshoff, Rossano Cesari, Dimitry Serge Antoine Nuyten, Ross Anthony Stewart, Fabian Zohren